Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Langer

Showing results (441-450 of 596) with videos related to

Pageof 60
Sort By:
Journal of the American College of Radiology : JACR|July 30, 2013
ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intentKenneth E Rosenzweig, Joe Yujiao Chang, Indrin J Chetty, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and HMatthew A Gubens, Lecia V Sequist, James P Stevenson, et al.
Oncoimmunology|November 2, 2013
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patientsJames P Stevenson, Hedy L Kindler, Emmanouil Papasavvas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2019
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)Corey J Langer, Mary W Redman, James L Wade, et al.
JCO Oncology Practice|May 27, 2020
Management of Lung Cancer During the COVID-19 PandemicAditi P Singh, Abigail T Berman, Melina E Marmarelis, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 studyShirish M Gadgeel, James P Stevenson, Corey J Langer, et al.
Cancer|October 21, 2018
Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs dataJoshua M Bauml, Ravi Vinnakota, Yeun-Hee Anna Park, et al.
Neurosurgical Focus|May 1, 2023
Dolichoectatic vertebrobasilar aneurysms: a systematic review and meta-analysis of management strategies and outcomesOthman Bin-Alamer, Jumanah Qedair, Paolo Palmisciano, et al.
Journal of Neurosurgery|December 6, 2024
The impact of cerebrovascular steno-occlusive disease subtype on surgical and clinical outcomes after direct STA-MCA bypass surgeryDanielle Golub, Joshua D McBriar, Shyle H Mehta, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2014
Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancerCorey J Langer, Istvan Albert, Helen J Ross, et al.
Pageof 60

Showing results (441-450 of 596) with videos related to

Sort By:
Pageof 60
Journal of the American College of Radiology : JACR|July 30, 2013
ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intentKenneth E Rosenzweig, Joe Yujiao Chang, Indrin J Chetty, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and HMatthew A Gubens, Lecia V Sequist, James P Stevenson, et al.
Oncoimmunology|November 2, 2013
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patientsJames P Stevenson, Hedy L Kindler, Emmanouil Papasavvas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2019
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)Corey J Langer, Mary W Redman, James L Wade, et al.
JCO Oncology Practice|May 27, 2020
Management of Lung Cancer During the COVID-19 PandemicAditi P Singh, Abigail T Berman, Melina E Marmarelis, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 studyShirish M Gadgeel, James P Stevenson, Corey J Langer, et al.
Cancer|October 21, 2018
Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs dataJoshua M Bauml, Ravi Vinnakota, Yeun-Hee Anna Park, et al.
Neurosurgical Focus|May 1, 2023
Dolichoectatic vertebrobasilar aneurysms: a systematic review and meta-analysis of management strategies and outcomesOthman Bin-Alamer, Jumanah Qedair, Paolo Palmisciano, et al.
Journal of Neurosurgery|December 6, 2024
The impact of cerebrovascular steno-occlusive disease subtype on surgical and clinical outcomes after direct STA-MCA bypass surgeryDanielle Golub, Joshua D McBriar, Shyle H Mehta, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2014
Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancerCorey J Langer, Istvan Albert, Helen J Ross, et al.
Pageof 60